The size of the Asia-Pacific mechanical ventilators market is valued at USD 0.79 billion in 2021 and is poised to reach USD 1.86 billion by 2026 forecasted to be growing at a healthy CAGR of 18.61% during the forecast period 2021 to 2026.
The increasing number of patients suffering from respiratory diseases such as asthma, lung cancer, cystic fibrosis, chronic obstructive pulmonary disease (COPD) will drive the market growth in the Asia-Pacific region. For example, according to recently released data, in 2019, around 47.7 million people in China suffered from asthma. Therefore, owing to such a large group of patients in the Chinese population, the market will show substantial growth during the analysis period.
In addition, the increased incidence of coronavirus disease in countries in the Asia-Pacific region will drive the market growth. For example, according to a recent released report by the World Health Organization (WHO), in 2020, the total number of patients affected by coronavirus disease was around 18,808. Therefore, countries experiencing rapid increase in coronavirus cases will drive the demand for mechanical ventilators, thus driving the market growth.
The absence of an adequate rebursement policies in developing and underdeveloped economies will derail the growth rate of the market. Moreover, the high costs associated with the ventilator will be an additional restrain for the growth of the market.
The increasing prevalence of coronavirus disease will generate the need for intensive care beds, which will improve the market demand. Since the Indian government banned the export of coronavirus-related medical products, including ventilators, this has resulted in ventilator shortages across the country. Therefore, companies are embracing partnerships and collaborations to deal with the COVID-19 pandemic and reduce shortage, thus providing opportunities for the future.
The strict regulations imposed by the government on the approval of new technologies will also hamper the growth rate of the market. In addition, the decrease in demand for invasive medical ventilation will create barriers.
This research report on the APAC mechanical ventilators market has been segmented and sub-segmented into the following categories:
By Product Type:
By Mode:
By End User:
By Country:
The Indian mechanical ventilator market is expected to grow at a CAGR of over 10.4% during the review period. The growing demand for life-saving machines to help support patients affected by COVID-19 will prompt companies across the country to increase production capacity. For example, according to the recent press article, in early 2020, Bharat Heavy Electricals Limited (BHEL) announced the manufacture of 30,100 ventilators for the treatment of COVID-19.
In addition, the Union Ministry of Health and Family has ordered a public sector company (PSU) to provide 10,500 ventilators to fight the coronavirus disease. Hence, increasing the production of ventilators across the country will boost the market growth. Moreover, the increasing burden of respiratory diseases across the country will drive the growth of the mechanical ventilators market in the years to come.
The increasing prevalence of chronic disease and the disproving heart health has led to a substantial increase in the number of heart attacks in countries like China and India, where the environment is also polluted every day supported by industrialization and has led to an increase in the spread of heart disease and led to increased use of medical ventilators for rapid recovery.
An increase in the geriatric population in APAC regions has led to an increase in health concerns and is boosting the deployment of medical ventilators in developed and developing economies across the regions and is expected to positively impact the growth of the market in the coming years.
KEY MARKET PLAYERS:
A few of the leading companies operating in the APAC Mechanical Ventilators Market profiled in the report are Dragerwerk AG & Co. KGaA, ResMed, Philips Healthcare, Medtronic Plc, GE Healthcare, Getinge Group, Smiths Medical, Fisher and Paykel Healthcare Limited, Dickinson and Company, Becton, and Hamilton Medical AG.
RECENT MARKET DEVELOPMENTS:
For example, in 2017, Air Liquide obtained OxyMaster and Sogo Sangyo Kabushiki Kaisha to the extent of the household healthcare portfolio throughout the Asia-Pacific region.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.1 Introduction
5.1.2 Critical Care
5.1.3 Neonatal Intensive Care
5.1.4 Portable
5.1.5 Transport
5.1.5 Y-o-Y Growth Analysis, By Product Type
5.1.6 Market Attractiveness Analysis, By Product Type
5.1.7 Market Share Analysis, By Product Type
5.2 Mode
5.2.1 Introduction
5.2.2 Invasive
5.2.3 Non-invasive
5.2.4 Y-o-Y Growth Analysis, By Mode
5.2.5 Market Attractiveness Analysis, By Mode
5.2.6 Market Share Analysis, By Mode
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Trauma Centres
5.3.4 Home Healthcare
5.3.5 Disease Risk Assessment
5.3.6 Other Applications
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
5.4 By Age Group
5.4.1 Pediatric and neonates
5.4.2 Adult
5.4.3 Geriatric
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product Type
6.1.3.3 By Mode
6.1.3.4 By End User
6.1.3.5 By Age Group
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product Type
6.1.4.3 By Mode
6.1.4.4 By End User
6.1.4.5 By Age Group
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product Type
6.1.5.3 By Mode
6.1.5.4 By End User
6.1.5.5 By Age Group
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Dragerwerk AG & Co. KGaA
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 ResMed
8.3 Philips Healthcare
8.4 Medtronic Plc
8.5 GE Healthcare
8.6 Getinge Group
8.7 Smiths Medical
8.8 Fisher and Paykel Healthcare Limited
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
